- 15351-09-41-Propanone,2-(dimethylamino)-1-phenyl-
- 15351-13-0b-D-Fructofuranose,1,3,4,6-tetra-3-pyridinecarboxylate
- 153512-22-2Uridine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-[3-oxo-3-[[2-[(trifluoroacetyl)amino]ethyl]amino]-1-propenyl]-,3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
- 153519-44-91,3-Benzenediol,4-[4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-, reaction products with2-[(dodecyloxy)methyl]oxirane and 2-[(C10-16-alkyloxy)methyl]oxirane
- 15352-74-62H-1,24:12,15-Dietheno-6,10-metheno-16H-pyrido[2',3':17,18][1,10]dioxacycloeicosino[2,3,4-ij]isoquinolin-9-ol,3,4,4a,5,16a,17,18,19-octahydro-21,22,26-trimethoxy-4,17-dimethyl-,hydrochloride (9CI)
- 153531-96-5TRI-MAGNESIUM DICITRATE NONAHYDRATE
- 153534-76-0Acetamide,2-iodo-N-(1-pyrenylmethyl)-
- 153556-42-4Benzoic acid,4-bromo-3-fluoro-
- 153559-45-6Benzoic acid,4-[(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)carbonyl]-, methylester
- 153559-46-7Benzoic acid,4-[(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)carbonyl]-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Buzepide methiodide |
EINECS | N/A |
| CAS No. | 15351-05-0 | Density | N/A |
| PSA | 43.09000 | LogP | 1.53180 |
| Solubility | N/A | Melting Point |
212-213 °C (decomp) |
| Formula | C23H31 N2 O . I | Boiling Point | N/A |
| Molecular Weight | 478.416 | Flash Point | N/A |
| Transport Information | N/A | Appearance | N/A |
| Safety | A poison by intraperitoneal, intravenous, intramuscular, and subcutaneous routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of I− and NOx. See also IODIDES. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
1-(3-Carbamoyl-3,3-diphenylpropyl)hexahydro-1-methylazepiniumiodide (6CI); 1H-Azepinium,1-(3-carbamoyl-3,3-diphenylpropyl)hexahydro-1-methyl-, iodide (8CI);1H-Azepinium, 1-(4-amino-4-oxo-3,3-diphenylbutyl)hexahydro-1-methyl-, iodide(9CI); 1-(3-Carbamoyl-3,3-diphenylpropyl) perhydro-1-methylazepinium iodide;2,2-Diphenyl-4-hexamethyleniminobutyramide methiodide; Buzepide methiodide;Buzepide metiodide; Difexamide methiodide; Diphexamide methiodide; FI 6146;Metazepium iodide; R 661; Spactin |
Buzepide methiodide Chemical Properties
IUPAC Name: 4-(1-Methylazepan-1-ium-1-yl)-2,2-diphenylbutanamide iodide
Synonyms of Buzepide methiodide (CAS NO.15351-05-0): Buzepide metiodide ; Buzepide metiodide [INN:DCF] ; 2,2-Diphenyl-4-N-hexamethyleniminobutyramide methiodide ; Buzepidi metiodidum ; Buzepidi metiodidum [INN-Latin] ; Difexamide methiodide ; Diphexamide methiodide ; EINECS 239-383-6 ; FI 6146 ; Metiodure de buzepide ; Metiodure de buzepide [INN-French] ; Metioduro de buzepida ; Metioduro de buzepida [INN-Spanish] ; R 661 ; Spactin ; UNII-5A9SS67K16 ; 1-(3-Carbamoyl-3,3-diphenylpropyl)perhydro-1-methylazepinium iodide ; 1-(4-Amino-4-oxo-3,3-diphenylbutyl)hexahydro-1-methyl-1H-azepinium iodide ; 1H-Azepinium, hexahydro-1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, iodide
CAS NO: 15351-05-0
Molecular Formula of Buzepide methiodide (CAS NO.15351-05-0): C23H31IN2O
Molecular Weight of Buzepide methiodide (CAS NO.15351-05-0): 478.4095
H bond acceptors: 3
H bond donors: 2
Freely Rotating Bonds: 6
Polar Surface Area: 20.31 Å2
Molecular Structure:
.bmp)
Buzepide methiodide Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intramuscular | 201mg/kg (201mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| mouse | LD50 | intraperitoneal | 94mg/kg (94mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| mouse | LD50 | intravenous | 14mg/kg (14mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| mouse | LD50 | oral | 820mg/kg (820mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| mouse | LD50 | subcutaneous | 229mg/kg (229mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| rat | LD50 | intramuscular | 800mg/kg (800mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| rat | LD50 | intraperitoneal | 145mg/kg (145mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| rat | LD50 | intravenous | 29300ug/kg (29.3mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| rat | LD50 | oral | 2800mg/kg (2800mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
| rat | LD50 | subcutaneous | 1210mg/kg (1210mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 1850, 1970. |
Buzepide methiodide Safety Profile
A poison by intraperitoneal, intravenous, intramuscular, and subcutaneous routes. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of I− and NOx. See also IODIDES.
What can I do for you?
Get Best Price
